NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor
NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
16.88 | |
18.04 | |
- | |
18.21 | |
16.35 | |
10.87-24.735 | |
1 827 M | |
108 M | |
550 M | |
-0.31 | |
0.71 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor
Asaf Danziger, Chief Executive Officer (Photo: Business Wire) Ashley Cordova, Chief Financial Officer (Photo: Business Wire) After 22 years as CEO, Asaf Danziger to retire at year end, will be succee...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: